Aeterna Zentaris
Aeterna Zentaris reports loss of $0.03 per share
Published in Health Business Week, September 15th, 2006
"During the second quarter, we made great strides in advancing our products through the pipeline at all stages as exemplified by Cetrotide's marketing approval in Japan, our successful meeting with the FDA leading to the upcoming filing of an IND to move forward into phase III clinical development of cetrorelix in benign prostatic hyperplasia (BPH), as well as the disclosure of positive clinical results in cancer with perifosine and AN-152. Most recently, we disclosed positive phase II results for ozarelix in prostate cancer which will enable us to...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
Source: Health Business Week (2006-09-15)
More Articles from Health Business Week
- AMDL
AMDL reports loss of $0.02 per share - AMS Health Sciences
AMS Health Sciences posts profit of $0.01 per share - Applied Imaging
Applied Imaging incurs loss of $0.06 per share - Applied NeuroSolutions
Dutton Associates maintains Speculative Buy Rating for Applied NeuroSolutions - Aspyra
Aspyra reports loss of $0.11 per share - Australian Pharmaceutical
Australian Pharmaceutical releases results for year ended 30 April 2006 - More from this issue of Health Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
